• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期对GLS1在炎症性疾病中的作用及治疗潜力的见解。

Recent insights into the roles and therapeutic potentials of GLS1 in inflammatory diseases.

作者信息

Sheng Jian-Xiang, Liu Yan-Jun, Yu Jing, Wang Ran, Chen Ru-Yi, Shi Jin-Jin, Yang Guan-Jun, Chen Jiong

机构信息

State Key Laboratory for Quality and Safety of Agro-Products, School of Marine Sciences, Ningbo University, Ningbo, Zhejiang, 315211, China.

出版信息

J Pharm Anal. 2025 Dec;15(12):101292. doi: 10.1016/j.jpha.2025.101292. Epub 2025 Apr 2.

DOI:10.1016/j.jpha.2025.101292
PMID:41450860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12731830/
Abstract

Glutaminase 1 (GLS1) is a crucial enzyme that serves as the initial rate-limiting factor in glutaminolysis, a metabolic process that releases various factors that influence biological processes such as development, differentiation, and immune responses. Several studies have systematically investigated the crucial role of GLS1 in cancer. However, there is a lack of a comprehensive understanding of the relationship between GLS1 and inflammation. In this review, we present a detailed examination of GLS1, and discuss its structure, function, and role in inflammatory pathways. Here, we summarize the evidence supporting GLS1's involvement in several inflammatory diseases and explore the potential therapeutic applications of GLS1 inhibitors. We found that GLS1 plays a crucial regulatory role in inflammation by mediating glutaminolysis. Targeting GLS1, such as through the use of GLS1 inhibitors, can effectively alleviate inflammation induced by GLS1. Furthermore, we highlight the challenges and opportunities associated with investigating GLS1 function and developing targeted inhibitors, and propose practical solutions that offer valuable insights for the functional exploration and discovery of potential therapeutics aimed at treating inflammatory diseases.

摘要

谷氨酰胺酶1(GLS1)是一种关键酶,它是谷氨酰胺分解代谢过程中的初始限速因子,谷氨酰胺分解代谢是一种释放多种影响发育、分化和免疫反应等生物学过程的因子的代谢过程。多项研究系统地探讨了GLS1在癌症中的关键作用。然而,目前对GLS1与炎症之间的关系缺乏全面的了解。在这篇综述中,我们对GLS1进行了详细的研究,并讨论了其结构、功能以及在炎症途径中的作用。在此,我们总结了支持GLS1参与多种炎症性疾病的证据,并探讨了GLS1抑制剂的潜在治疗应用。我们发现GLS1通过介导谷氨酰胺分解代谢在炎症中发挥关键的调节作用。靶向GLS1,例如使用GLS1抑制剂,可以有效减轻GLS1诱导的炎症。此外,我们强调了研究GLS1功能和开发靶向抑制剂所面临的挑战与机遇,并提出了切实可行的解决方案,这些方案为旨在治疗炎症性疾病的潜在治疗方法的功能探索和发现提供了有价值的见解。

相似文献

1
Recent insights into the roles and therapeutic potentials of GLS1 in inflammatory diseases.近期对GLS1在炎症性疾病中的作用及治疗潜力的见解。
J Pharm Anal. 2025 Dec;15(12):101292. doi: 10.1016/j.jpha.2025.101292. Epub 2025 Apr 2.
2
Glutaminase 1 inhibitors: Therapeutic potential, mechanisms of action, and clinical perspectives.谷氨酰胺酶1抑制剂:治疗潜力、作用机制及临床前景
Biochem Pharmacol. 2025 Aug 22;242(Pt 1):117275. doi: 10.1016/j.bcp.2025.117275.
3
Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics.通过小分子靶向谷氨酰胺酶1(GLS1)用于抗癌治疗。
Eur J Med Chem. 2023 Apr 5;252:115306. doi: 10.1016/j.ejmech.2023.115306. Epub 2023 Mar 23.
4
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents.解析变构谷氨酰胺酶1抑制剂作为抗癌药物的作用机制
Bioorg Chem. 2025 Jul 1;161:108523. doi: 10.1016/j.bioorg.2025.108523. Epub 2025 Apr 26.
5
Mycobacterium manipulate glutaminase 1 mediated glutaminolysis to regulate macrophage autophagy for bacteria intracellular survival.分枝杆菌操纵谷氨酰胺酶 1 介导的谷氨酰胺分解代谢来调节巨噬细胞自噬以实现细菌的细胞内生存。
Cell Signal. 2024 Dec;124:111422. doi: 10.1016/j.cellsig.2024.111422. Epub 2024 Sep 20.
6
Bergenin, a PPARγ agonist, inhibits Th17 differentiation and subsequent neutrophilic asthma by preventing GLS1-dependent glutaminolysis.没食子酰基 Bergenin 通过抑制 GLS1 依赖性谷氨酰胺分解来抑制 Th17 分化和随后的中性粒细胞性哮喘。
Acta Pharmacol Sin. 2022 Apr;43(4):963-976. doi: 10.1038/s41401-021-00717-1. Epub 2021 Jul 15.
7
Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.谷氨酰胺酶的高表达通过前列腺癌中的谷氨酰胺分解赋予葡萄糖利用能力。
Biochem Biophys Res Commun. 2015 Jan 2;456(1):452-8. doi: 10.1016/j.bbrc.2014.11.105. Epub 2014 Dec 4.
8
Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.抑制谷氨酰胺酶 1 介导的谷氨酰胺分解可改善病理性心脏重构。
Am J Physiol Heart Circ Physiol. 2022 May 1;322(5):H749-H761. doi: 10.1152/ajpheart.00692.2021. Epub 2022 Mar 11.
9
Glutaminase-1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells.谷氨酰胺酶-1介导的谷氨酰胺分解至谷胱甘肽合成维持氧化还原稳态并调节癌细胞中的铁死亡敏感性。
Cell Prolif. 2025 Apr 21:e70036. doi: 10.1111/cpr.70036.
10
Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer.谷氨酰胺酶通过调节结直肠癌中的糖酵解和谷氨酰胺分解来维持细胞存活。
Oncol Lett. 2017 Sep;14(3):3117-3123. doi: 10.3892/ol.2017.6538. Epub 2017 Jul 7.

引用本文的文献

1
Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases.CAR-T疗法在自身免疫性疾病临床应用中的挑战与策略
J Hematol Oncol. 2025 Nov 28;19(1):1. doi: 10.1186/s13045-025-01769-0.

本文引用的文献

1
Inhibition of glutaminase 1 reduces M1 macrophage polarization to protect against monocrotaline-induced pulmonary arterial hypertension.抑制谷氨酰胺酶1可减少M1巨噬细胞极化,从而预防野百合碱诱导的肺动脉高压。
Immunol Lett. 2025 Apr;272:106974. doi: 10.1016/j.imlet.2025.106974. Epub 2025 Jan 5.
2
LC-MS analysis of chiral amino acids in human urine reveals D-amino acids as potential biomarkers for colorectal cancer.LC-MS 分析人尿液中的手性氨基酸揭示 D-氨基酸可能作为结直肠癌的生物标志物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Sep 15;1245:124270. doi: 10.1016/j.jchromb.2024.124270. Epub 2024 Aug 5.
3
SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism the MEK/ERK/C-Myc Axis.
SIRT4 通过抑制谷氨酰胺代谢和 MEK/ERK/C-Myc 轴发挥抑癌作用在宫颈癌中。
Anticancer Res. 2024 Jul;44(7):2861-2870. doi: 10.21873/anticanres.17098.
4
The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis.随着脂肪性肝病进展为脂肪性肝炎,脂多糖-TLR4轴调节肝谷氨酰胺酶1的表达,促进肝脏氨蓄积。
Metabolism. 2024 Sep;158:155952. doi: 10.1016/j.metabol.2024.155952. Epub 2024 Jun 19.
5
Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.缺氧诱导因子-2α 通过增强肝星状细胞中的谷氨酰胺分解代谢和抑制 yes 相关蛋白磷酸化来促进非酒精性脂肪性肝病中的纤维化。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1344971. doi: 10.3389/fendo.2024.1344971. eCollection 2024.
6
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate.聚焦筛选鉴定人 TET 加氧酶对致癌代谢物 2-羟戊二酸的不同敏感性。
J Med Chem. 2024 Mar 28;67(6):4525-4540. doi: 10.1021/acs.jmedchem.3c01820. Epub 2024 Jan 31.
7
Tumor-derived Exosomal ENO2 Modulates Polarization of Tumor-associated Macrophages through Reprogramming Glycolysis to Promote Progression of Diffuse Large B-cell Lymphoma.肿瘤来源的外泌体 ENO2 通过重编程糖酵解来调节肿瘤相关巨噬细胞的极化,从而促进弥漫性大 B 细胞淋巴瘤的进展。
Int J Biol Sci. 2024 Jan 1;20(3):848-863. doi: 10.7150/ijbs.91154. eCollection 2024.
8
Short-term administration of Qipian®, a mixed bacterial lysate, inhibits airway inflammation in ovalbumin-induced mouse asthma by modulating cellular, humoral and neurogenic immune responses.奇蹟®(一种混合細菌裂解物)短期治療可透過調節細胞、液體和神經免疫反應抑制卵白蛋白誘導的小鼠哮喘的氣道炎症。
Life Sci. 2024 Jan 1;336:122310. doi: 10.1016/j.lfs.2023.122310. Epub 2023 Nov 25.
9
Gut-derived ammonia contributes to alcohol-related fatty liver development via facilitating ethanol metabolism and provoking ATF4-dependent de novo lipogenesis activation.肠道来源的氨通过促进乙醇代谢和激活ATF4依赖的从头脂肪生成,促进酒精性脂肪肝的发展。
Metabolism. 2024 Feb;151:155740. doi: 10.1016/j.metabol.2023.155740. Epub 2023 Nov 22.
10
SIRT4 protects against intestinal fibrosis by facilitating GLS1 degradation.SIRT4 通过促进 GLS1 降解来保护肠道免于纤维化。
Matrix Biol. 2023 Sep;122:33-45. doi: 10.1016/j.matbio.2023.08.001. Epub 2023 Aug 2.